11/17/2025
DCI is participating in a national clinical trial that could reshape the future of CAR T-cell therapy for patients with aggressive lymphoma.
https://duke.is/w/8xat
Duke University School of Medicine | Duke Health
Duke Cancer Institute is participating in a national clinical trial that could reshape the future of CAR T-cell therapy for patients with aggressive lymphoma.